The FDA cleared Flyp device is intended for general purpose of nebulizer, like ipratropium bromide, albuterol, cromolyn sodium, and budesonide in addition to other medications. The device is powered by a lithium-ion battery and is rechargeable via a micro USB. Furthermore, the device is capable of 8 to 10 treatments on a full charge which roughly requires about an hour and a half.
Flyp tackles a uniform mist of 2-3 micron particles by means of an internal and perforated disk which vibrates through an ultrasonic speed. After medication passes via the disk’s holes, the device produces an inhalable aerosol mist. The time needed to dispense the medication is also shortened to minutes in case of most of the medications.
The Flyp nebulizer was created by Dr Ralph Finger and is produced by Convexity Scientific Inc.
According to reports, most of the DME pharmacy clients are accustomed to home respiratory aids or to drugs delivery, especially among COPD, asthma and cystic fibrosis patients. It is observed that most of these patients are youngsters and elders who face trouble either managing or remembering medications.
Manufactures are thus offering improved drug delivery devices with enhanced features which thus help to improve delivery and also enable to measure performance of the devices and also in some cases that of the patient.
“One of the challenges physicians are faced with in caring for their asthma and COPD patients is knowing if their patients are using their inhaled medication as they should,” comments Tushar Shah, M.D., global head of Specialty Clinical Development & Medical Affairs at Teva Pharmaceuticals. “Offering a tool that enables doctors to see data on their patients’ inhaler usage will allow them to have more productive conversations about identifying issues and how to manage their illness,” he adds.
Device monitoring therefore also focuses on helping the patient before they need a scheduled or an unscheduled visit to the doctor. “Digital medicines provide patients with a greater sense of control over their disease by placing the tools to self-manage in the palm of their hand,” according to Chris Hogg, chief commercial officer for Propeller Health. “With a digital medicine, a patient can use their smartphone or computer to remind them to take their medicine, understand when and where they’ve been experiencing exacerbations, communicate with their provider on their symptoms and gain insights into what triggers their exacerbations.”
Remote monitoring is thus the latest technology feature among CPAP devices, including some of the sleep devices. With the introduction of Bluetooth and 4G and 5G features, healthcare has paved way for advanced monitoring in portable devices. Application of real data in the field of Medicare has thus become the need of the hour.